成人实体器官移植候选者三种脊髓灰质炎病毒血清型抗体血清阳性率及灭活疫苗应答
研究纳入2013年3月至2016年1月转诊至Evandro Chagas国家传染病研究所免疫参考中心的206例成人实体器官移植候选者,采用横断面血清阳性率研究及无对照疫苗应答分析。76%(95%CI:70-81%)的候选者对全部三种脊髓灰质炎病毒血清型具有保护性抗体滴度,基线无保护性抗体者中97%在接种一剂灭活脊髓灰质炎疫苗后产生 adequate 疫苗应答。作者认为一剂灭活疫苗应在实体器官移植前常规处方。
要点
- 206例成人实体器官移植候选者中76%(95%CI:70-81%)对全部三种脊髓灰质炎病毒血清型有保护性抗体。
- 儿童期口服疫苗史与保护性抗体血清阳性率较高无关。
- 基线无保护性抗体者中97%接种一剂灭活脊髓灰质炎疫苗后产生 adequate 疫苗应答。
核心结论
- 相当比例的成人实体器官移植候选者对一种或多种脊髓灰质炎病毒血清型缺乏保护性抗体滴度。
- 一剂灭活疫苗在97%的基线无保护性抗体受试者中 elicits 保护性抗体滴度,应在实体器官移植前常规处方。
研究设计与样本
- 研究纳入2013年3月至2016年1月转诊至Evandro Chagas国家传染病研究所免疫参考中心的实体器官移植候选者,共206例。
- 研究分两阶段:第一阶段为横断面血清阳性率研究,第二阶段对基线无保护性抗体滴度的患者进行无对照疫苗应答分析。
- 脊髓灰质炎抗体滴度采用微量中和试验测定。
主要发现
- 206例实体器官移植候选者中,156例(76%)对全部脊髓灰质炎病毒血清型具有保护性抗体滴度(95%CI:70-81%)。
- 儿童期口服疫苗接种的确证史与保护性抗体血清阳性率较高无关。
- 基线无保护性抗体滴度的个体中,97%在接种一剂灭活脊髓灰质炎疫苗后产生 adequate 疫苗应答。
临床怎么用
- 作者认为一剂灭活脊髓灰质炎疫苗应在实体器官移植前常规处方。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the prevalence of protective antibody titers to polioviruses in adults candidates for solid organ transplant (SOT), and to assess the immunogenic response to inactivated polio vaccine in this population. METHODS: The study included SOT candidates referred to Immunization Reference Centre of Evandro Chagas National Institute of Infectious Diseases from March 2013 to January 2016. It was conducted in 2 phases. The first one, a cross-sectional seroprevalence study, followed by an uncontrolled analysis of vaccine response among patients without protective antibody titers at baseline. Antibody titers to poliomyelitis were determined by microneutralization assay. RESULTS: Among 206 SOT candidates included, 156 (76%) had protective antibody titers to all poliovirus serotypes (95% CI: 70-81%). Proven history of oral vaccination in childhood was not associated with higher seroprevalence of protective antibody. In 97% of individuals without protective antibody titers at baseline, there was adequate vaccine response with one dose of inactivated polio vaccine. CONCLUSIONS: A relevant proportion of adult candidates for SOT does not have protective titers of antibodies to one or more poliovirus serotype. One dose of inactivated vaccine elicited protective antibody titers in 97% of these subjects and should be routinely prescribed prior to SOT.
引用
- Brandão LGP, Santoro-Lopes G, Oliveira SS, et al. Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates. Vaccine. 2018. PMID: 29937244. doi:10.1016/j.vaccine.2018.06.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。